Nitin Rohatgi

603 total citations
7 papers, 62 citations indexed

About

Nitin Rohatgi is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nitin Rohatgi has authored 7 papers receiving a total of 62 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nitin Rohatgi's work include Radiomics and Machine Learning in Medical Imaging (2 papers), AI in cancer detection (2 papers) and Cancer Genomics and Diagnostics (2 papers). Nitin Rohatgi is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (2 papers), AI in cancer detection (2 papers) and Cancer Genomics and Diagnostics (2 papers). Nitin Rohatgi collaborates with scholars based in United States. Nitin Rohatgi's co-authors include Elyse E. Lower, Robbin Blau, Meredith C. Henderson, David E. Reese, Ana P. Lourenço, Michael Silver, Mehmet Asım Bilen, Judith K. Wolf, Joshua LaBaer and Kenneth A. Foon and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Nitin Rohatgi

7 papers receiving 60 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nitin Rohatgi United States 5 27 24 22 15 10 7 62
Cornelia Kolberg-Liedtke Germany 5 58 2.1× 36 1.5× 23 1.0× 20 1.3× 6 0.6× 14 90
Natalie J. Kurganovs Australia 6 23 0.9× 32 1.3× 43 2.0× 25 1.7× 4 0.4× 9 93
Ana Bosch Campos Sweden 3 15 0.6× 20 0.8× 13 0.6× 10 0.7× 7 0.7× 3 35
JMS Bartlett United Kingdom 6 39 1.4× 43 1.8× 11 0.5× 14 0.9× 15 1.5× 14 82
Geoffrey Fell United States 4 20 0.7× 21 0.9× 22 1.0× 14 0.9× 4 0.4× 10 70
Sukanya Panja United States 7 17 0.6× 28 1.2× 47 2.1× 40 2.7× 9 0.9× 9 89
P. Hill Australia 5 46 1.7× 43 1.8× 43 2.0× 12 0.8× 3 0.3× 7 103
Heejoon Jo United States 7 23 0.9× 35 1.5× 47 2.1× 15 1.0× 5 0.5× 14 75
Daniel P. Miller United States 2 10 0.4× 21 0.9× 37 1.7× 14 0.9× 7 0.7× 2 70
Vincent Cockenpot France 6 25 0.9× 18 0.8× 28 1.3× 16 1.1× 30 3.0× 14 84

Countries citing papers authored by Nitin Rohatgi

Since Specialization
Citations

This map shows the geographic impact of Nitin Rohatgi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nitin Rohatgi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nitin Rohatgi more than expected).

Fields of papers citing papers by Nitin Rohatgi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nitin Rohatgi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nitin Rohatgi. The network helps show where Nitin Rohatgi may publish in the future.

Co-authorship network of co-authors of Nitin Rohatgi

This figure shows the co-authorship network connecting the top 25 collaborators of Nitin Rohatgi. A scholar is included among the top collaborators of Nitin Rohatgi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nitin Rohatgi. Nitin Rohatgi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Yang, Eddy S., Susan Halabi, Michael Rothe, et al.. (2023). Olaparib in Patients With Metastatic Prostate Cancer With BRCA1/2 Mutation: Results From the TAPUR Study. JCO Precision Oncology. 7(7). e2200505–e2200505. 5 indexed citations
2.
3.
Pisick, Evan, Elizabeth Garrett‐Mayer, Susan Halabi, et al.. (2020). Olaparib (O) in patients (pts) with prostate cancer with BRCA1/2 inactivating mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.. Journal of Clinical Oncology. 38(15_suppl). 5567–5567. 2 indexed citations
4.
Henderson, Meredith C., Michael Silver, David E. Reese, et al.. (2018). A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment. Clinical Cancer Research. 25(1). 142–149. 17 indexed citations
5.
Lourenço, Ana P., Meredith C. Henderson, Michael Silver, et al.. (2017). A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years. Clinical Breast Cancer. 17(7). 516–525.e6. 21 indexed citations
6.
Rohatgi, Nitin, Robbin Blau, & Elyse E. Lower. (2002). Raloxifene Is Associated with Less Side Effects Than Tamoxifen in Women with Early Breast Cancer: A Questionnaire Study from One Physician's Practice. Journal of Women s Health & Gender-Based Medicine. 11(3). 291–301. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026